Ecog-Acrin Medical Research Foundation Inc
- Assets
- $11.6m
- Revenue
- $49.3m
- Investments
- $0.0
- Employees
- 133
- Location
- Philadelphia, PA
- Founding
- 07/2013
- Data as of
- 12/2021
- EIN
- 46-0745339
Organization Overview
Ecog-Acrin Medical Research Foundation Inc is located in Philadelphia, PA. The organization was established in 2013. According to its NTEE Classification (G05) the organization is classified as: Research Institutes & Public Policy Analysis, under the broad grouping of Voluntary Health Associations & Medical Disciplines and related organizations. As of 12/2021, Ecog-Acrin Medical Research Foundation Inc employed 133 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Ecog-Acrin Medical Research Foundation Inc is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2021, Ecog-Acrin Medical Research Foundation Inc generated $49.3m in total revenue. This organization has experienced exceptional growth, as over the past 7 years, it has increased revenue by an average of 14.4% each year . All expenses for the organization totaled $48.9m during the year ending 12/2021. While expenses have increased by 14.3% per year over the past 7 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2021
Describe the Organization's Mission:
Part 3 - Line 1
THE PURPOSE OF ECOG-ACRIN MEDICAL RESEARCH FOUNDATION, INC. IS TO FOSTER CLINICAL RESEARCH WITHIN THE PUBLIC, NON-PROFIT AND PRIVATE SECTORS FOR THE DETECTION, DIAGNOSIS, PREVENTION AND TREATMENT OF CANCER AND OTHER RELATED DISEASES, INCLUDING THROUGH DEVELOPING TECHNOLOGY TO PREDICT PROGNOSIS AND RESPONSES TO THERAPEUTIC INTERVENTION FOR PATIENTS WITH CANCER AND OTHER RELATED DISEASES, THAT WILL ULTIMATELY IMPROVE THE OUTCOMES FOR CANCER PATIENTS.
Describe the Organization's Program Activity:
Part 3 - Line 4a
FEDERAL GRANTS THE ECOG-ACRIN MEDICAL RESEARCH FOUNDATION INC., THROUGH ITS FEDERAL FUNDING, BOTH DIRECT AND AS A SUBRECIPIENT, SUPPORTS THE EFFORTS OF THE NCI TO IMPROVE OUTCOMES FOR CANCER PATIENTS. THIS FEDERAL FUNDING AIDS ECOG- ACRIN IN PROVIDING THE SUPPORT NECESSARY TO CONDUCT RELEVANT AND RIGOROUS CLINICAL TRIALS, WHICH BENEFIT PUBLIC HEALTH BY IMPROVING THE QUANTITY AND STANDARD OF CARE FOR CANCER PATIENTS. IN ADDITION, THE FUNDS ARE USED TO PROMOTE COLLABORATION ACROSS A PROLIFIC SCIENTIFIC COMMUNITY AND TO CONTINUE THE STRONG ENGAGEMENT OF PATIENT ADVOCACY AT ALL LEVELS.
PHARMACEUTICAL GRANTS THROUGH SUPPLEMENTAL FUNDING ON NCI APPROVED AND FUNDED TRIALS, ECOG-ACRIN MEDICAL RESEARCH FOUNDATION INC. CARRIES OUT ACTIVITIES DESCRIBED IN THE SCOPE OF FUNCTIONS OF EACH NCI PROTOCOL. ALL FUNCTIONS ARE PERFORMED IN COMPLIANCE WITH FEDERAL, STATE AND LOCAL LAWS, WITH AN OVERARCHING GOAL OF REACHING FULL ACCRUALS TO FURTHER ADVANCE THE RESEARCH AND MEDICINE AIMED AT IMPROVING OUTCOMES FOR CANCER PATIENTS.
FEDERAL CONTRACTS THE ECOG-ACRIN MEDICAL RESEARCH FOUNDATION INC., THROUGH ITS SUBRECIPIENT FEDERAL CONTRACT FUNDING FOR THE NCI MATCH AND MDS PROGRAMS AIDS ECOG-ACRIN IN PROVIDING THE SUPPORT NECESSARY TO CONDUCT SPECIFIC RELEVANT AND RIGOROUS CLINICAL TRIALS, WHICH AIM TO BENEFIT THE PUBLIC HEALTH BY IMPROVING THE QUANTITY AND STANDARD OF CARE FOR CANCER PATIENTS.
OTHER PROGRAM SERVICES INDUSTRY PAYMENTS THE ECOG-ACRIN MEDICAL RESEARCH FOUNDATION INC. ALSO RECEIVES FUNDING ON BEHALF OF OTHER NCI-FUNDED CANCER COOPERATIVE GROUPS IN SUPPORT OF EFFORTS TAKEN BY INDIVIDUAL SITES THAT ARE CREDITED AS ECOG-ACRIN INSTITUTIONS ALIGNED WITH THE MISSION TO IMPROVE THE OUTCOMES FOR CANCER PATIENTS. THIS AND OTHER FUNDING IS PRIMARILY PASS-THROUGH PAYMENTS FROM OTHER GROUPS AND IS PASSED ALONG TO THE ECOG-ACRIN CREDITED SITES. THESE FUNDS ARE USED BY INSTITUTIONS TO CONTINUE THEIR COLLECTIVE EFFORTS OF CONDUCTING RELEVANT AND RIGOROUS CLINICAL TRIALS, WHICH AIM TO BENEFIT PUBLIC HEALTH BY IMPROVING THE QUANTITY AND STANDARD OF CARE FOR CANCER PATIENTS.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Donna Marinucci Executive Di | Officer | 40 | $266,036 |
Jean Macdonald Deputy Exec | 40 | $235,280 | |
Kenneth Rockwell Dir Regulato | 40 | $192,497 | |
Pamela Cogliano Director Of | 40 | $177,331 | |
Kerry Higgins Director Dat | 40 | $174,353 | |
Mitchell Schnall MD PHD Secretary/tr | OfficerTrustee | 4 | $0 |
Outside Vendors & Contractors
| Vendor Name (Service) | Service Year | Compensation |
|---|---|---|
Coalition Of Cancer Cooperative Grps Salary Support | 12/30/21 | $3,265,669 |
Gayle Ipock Consultant | 12/30/21 | $253,521 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $0 |
| Membership dues | $0 |
| Fundraising events | $0 |
| Related organizations | $0 |
| Government grants | $46,012,061 |
| All other contributions, gifts, grants, and similar amounts not included above | $3,762 |
| Noncash contributions included in lines 1a–1f | $0 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $46,015,823 |
| Total Program Service Revenue | $3,254,604 |
| Investment income | $0 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $0 |
| Net Rental Income | $0 |
| Net Gain/Loss on Asset Sales | $0 |
| Net Income from Fundraising Events | $0 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $49,270,427 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $0 |
| Grants and other assistance to domestic individuals. | $0 |
| Grants and other assistance to Foreign Orgs/Individuals | $0 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $0 |
| Compensation of current officers, directors, key employees. | $0 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $7,325,263 |
| Pension plan accruals and contributions | $237,122 |
| Other employee benefits | $2,069,983 |
| Payroll taxes | $697,167 |
| Fees for services: Management | $0 |
| Fees for services: Legal | $1,590 |
| Fees for services: Accounting | $40,600 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $0 |
| Fees for services: Other | $631,811 |
| Advertising and promotion | $0 |
| Office expenses | $301,769 |
| Information technology | $0 |
| Royalties | $0 |
| Occupancy | $1,439,203 |
| Travel | $15,271 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $95,598 |
| Interest | $2,850 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $136,137 |
| Insurance | $17,585 |
| All other expenses | $355,700 |
| Total functional expenses | $48,907,395 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $2,224,964 |
| Savings and temporary cash investments | $0 |
| Pledges and grants receivable | $0 |
| Accounts receivable, net | $8,808,341 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $71,029 |
| Net Land, buildings, and equipment | $379,099 |
| Investments—publicly traded securities | $0 |
| Investments—other securities | $0 |
| Investments—program-related | $0 |
| Intangible assets | $0 |
| Other assets | $140,692 |
| Total assets | $11,624,125 |
| Accounts payable and accrued expenses | $4,627,299 |
| Grants payable | $0 |
| Deferred revenue | $806,446 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $0 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $0 |
| Total liabilities | $5,433,745 |
| Net assets without donor restrictions | $6,190,380 |
| Net assets with donor restrictions | $0 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $0 |
| Total liabilities and net assets/fund balances | $11,624,125 |
Grants Recieved
Over the last fiscal year, we have identified 3 grants that Ecog-Acrin Medical Research Foundation Inc has recieved totaling $457,757.
| Awarding Organization | Amount |
|---|---|
Breast Cancer Research Foundation Inc New York, NY PURPOSE: MEDICAL RESEARCH | $225,000 |
Alliance For Clinical Trials In Oncology Foundation Chicago, IL PURPOSE: CANCER RESEARCH | $191,051 |
Montefiore Medical Center Bronx, NY PURPOSE: GRANT SUBRECIPIENT | $41,706 |
Peer Organizations
| Organization Name | Assets | Revenue |
|---|---|---|
Ecog-Acrin Medical Research Foundation Inc Philadelphia, PA | $11,624,125 | $49,270,427 |
Next For Autism Inc New York, NY | $6,631,395 | $5,308,625 |
Foxg1 Research Inc Sands Point, NY | $2,520,850 | $2,803,193 |
Thanc Foundation Inc New York, NY | $5,679,438 | $1,339,976 |
Pediatric Nephrology Research Consortium Columbus, OH | $198,979 | $487,928 |
Riaan Research Initiative Inc Oakland Gardens, NY | $1,140,975 | $1,515,797 |
Heart Valve Collaboratory Inc New York, NY | $181,917 | $300,000 |
American Acne And Rosacea Society Montclair, NJ | $643,788 | $177,478 |
Mho Research Foundation Inc New York, NY | $289,774 | $80,414 |
Integrative Medicine Foundation Inc Cincinnati, OH | $438,389 | $35,157 |
Multiple Sclerosis Research Institute Philadelphia, PA | $453,092 | $0 |
The New York Glaucoma Research Institute New York, NY | $1,205,090 | $29,192 |